期刊
CELL REPORTS
卷 39, 期 1, 页码 -出版社
CELL PRESS
DOI: 10.1016/j.celrep.2022.110584
关键词
-
类别
资金
- KWF Kankerbestrijding [UU2014-7201]
- Dutch Research Council TOP grant [NWO-TOP 02007]
- European Union's Horizon 2020 FET Proactive program [731957 (MECHANO-CONTROL)]
Elevated expression of non-receptor tyrosine kinase FER is associated with poor prognosis in breast cancer patients, particularly in high-grade and basal/triple-negative cases. However, high FER levels are correlated with improved outcomes after adjuvant taxane-based chemotherapy in high-risk, HER2-negative patients. Mechanistic studies reveal that FER regulates endosomal recycling and its inhibition leads to reduced breast cancer cell invasion. Furthermore, DCTN2 is identified as a substrate of FER, and its phosphorylation at tyrosine 6 is essential for tubular recycling domains formation and TNBC cell invasion.
Elevated expression of non-receptor tyrosine kinase FER is an independent prognosticator that correlates with poor survival of high-grade and basal/triple-negative breast cancer (TNBC) patients. Here, we show that high FER levels are also associated with improved outcomes after adjuvant taxane-based combination chemotherapy in high-risk, HER2-negative patients. In TNBC cells, we observe a causal relation between high FER levels and sensitivity to taxanes. Proteomics and mechanistic studies demonstrate that FER regulates endosomal recycling, a microtubule-dependent process that underpins breast cancer cell invasion. Using chemical genetics, we identify DCTN2 as a FER substrate. Our work indicates that the DCTN2 tyrosine 6 is essential for the development of tubular recycling domains in early endosomes and subsequent propagation of TNBC cell invasion in 3D. In conclusion, we show that high FER expression promotes endosomal recycling and represents a candidate predictive marker for the benefit of adjuvant taxane-containing chemotherapy in high-risk patients, including TNBC patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据